Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5702783 | Urologic Oncology: Seminars and Original Investigations | 2016 | 10 Pages |
Abstract
More than one third of RC patients overexpress HER2 in their tumors. HER2 overexpression was associated with features of biological and clinical aggressiveness. HER2 did not add prognostic significance to the standard established predictors of survival outcomes after RC. However, due to the high overexpression rate, it could represent a target for therapy in select advanced BCa tumors.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Francesco MD, Marco MD, Andrea MD, Gregory J. MD, Kilian M. MD, Alberto MD, Morgan M.D., Ph.D., Tobias M.D., Melanie R. Ph.D., Pierre I. M.D., Shahrokh F. Ph.D.,